Time-to-first-event versus recurrent-event analysis: points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints
Background Composite endpoints combining several event types of clinical interest often define the primary efficacy outcome in cardiologic trials. They are commonly evaluated as time-to-first-event,...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2018
|
| In: |
Clinical research in cardiology
Year: 2018, Volume: 107, Issue: 5, Pages: 437-443 |
| ISSN: | 1861-0692 |
| DOI: | 10.1007/s00392-018-1205-7 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1007/s00392-018-1205-7 Verlag, Volltext: https://link.springer.com/article/10.1007/s00392-018-1205-7 
|
| Author Notes: | Geraldine Rauch, Meinhard Kieser, Harald Binder, Antoni Bayes-Genis, Antje Jahn-Eimermacher |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1665015276 | ||
| 003 | DE-627 | ||
| 005 | 20220816145740.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190508s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00392-018-1205-7 |2 doi | |
| 035 | |a (DE-627)1665015276 | ||
| 035 | |a (DE-599)KXP1665015276 | ||
| 035 | |a (OCoLC)1341212518 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Rauch, Geraldine |e VerfasserIn |0 (DE-588)139823492 |0 (DE-627)61378944X |0 (DE-576)313422923 |4 aut | |
| 245 | 1 | 0 | |a Time-to-first-event versus recurrent-event analysis |b points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints |c Geraldine Rauch, Meinhard Kieser, Harald Binder, Antoni Bayes-Genis, Antje Jahn-Eimermacher |
| 264 | 1 | |c 2018 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 16 February 2018 | ||
| 500 | |a Gesehen am 08.05.2019 | ||
| 520 | |a Background Composite endpoints combining several event types of clinical interest often define the primary efficacy outcome in cardiologic trials. They are commonly evaluated as time-to-first-event,... | ||
| 700 | 1 | |a Kieser, Meinhard |d 1960- |e VerfasserIn |0 (DE-588)103276547X |0 (DE-627)739277766 |0 (DE-576)168963825 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical research in cardiology |d Berlin : Springer, 2006 |g 107(2018), 5, Seite 437-443 |h Online-Ressource |w (DE-627)506287343 |w (DE-600)2218331-0 |w (DE-576)251097692 |x 1861-0692 |7 nnas |a Time-to-first-event versus recurrent-event analysis points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints |
| 773 | 1 | 8 | |g volume:107 |g year:2018 |g number:5 |g pages:437-443 |g extent:7 |a Time-to-first-event versus recurrent-event analysis points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00392-018-1205-7 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00392-018-1205-7 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190508 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 103276547X |a Kieser, Meinhard |m 103276547X:Kieser, Meinhard |d 910000 |d 999701 |e 910000PK103276547X |e 999701PK103276547X |k 0/910000/ |k 1/910000/999701/ |p 2 | ||
| 998 | |g 139823492 |a Rauch, Geraldine |m 139823492:Rauch, Geraldine |d 50000 |e 50000PR139823492 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1665015276 |e 3472255854 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1665015276","physDesc":[{"extent":"7 S."}],"name":{"displayForm":["Geraldine Rauch, Meinhard Kieser, Harald Binder, Antoni Bayes-Genis, Antje Jahn-Eimermacher"]},"id":{"eki":["1665015276"],"doi":["10.1007/s00392-018-1205-7"]},"relHost":[{"recId":"506287343","pubHistory":["95.2006 -"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2218331-0"],"issn":["1861-0692"],"eki":["506287343"]},"disp":"Time-to-first-event versus recurrent-event analysis points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpointsClinical research in cardiology","language":["eng"],"part":{"issue":"5","extent":"7","volume":"107","year":"2018","text":"107(2018), 5, Seite 437-443","pages":"437-443"},"title":[{"title":"Clinical research in cardiology","title_sort":"Clinical research in cardiology"}],"origin":[{"publisher":"Springer","dateIssuedKey":"2006","dateIssuedDisp":"2006-","publisherPlace":"Berlin"}],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"person":[{"display":"Rauch, Geraldine","family":"Rauch","role":"aut","given":"Geraldine"},{"display":"Kieser, Meinhard","family":"Kieser","role":"aut","given":"Meinhard"}],"language":["eng"],"origin":[{"dateIssuedDisp":"2018","dateIssuedKey":"2018"}],"note":["Published online: 16 February 2018","Gesehen am 08.05.2019"],"title":[{"title_sort":"Time-to-first-event versus recurrent-event analysis","subtitle":"points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints","title":"Time-to-first-event versus recurrent-event analysis"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a RAUCHGERALTIMETOFIRS2018 | ||